Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
bioAffinity Technologies, Inc. ( (BIAF) ) just unveiled an update.
On September 2, 2025, bioAffinity Technologies, Inc. announced an agreement with warrant holders to amend the Floor Price of its May and August 2025 Warrants, increasing it from $0.10 to $0.15. This amendment, effective as of August 12, 2025, resulted in a reduction of shares issuable upon exercise of the May 2025 Warrants from 53,377,497 to 35,584,997, while the August 2025 Warrants remain subject to shareholder approval.
The most recent analyst rating on (BIAF) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on bioAffinity Technologies, Inc. stock, see the BIAF Stock Forecast page.
Spark’s Take on BIAF Stock
According to Spark, TipRanks’ AI Analyst, BIAF is a Neutral.
The overall stock score of 47 reflects significant financial challenges and a bearish technical outlook, partially offset by positive corporate events. The company’s financial performance is the most significant factor, with negative profitability and increasing leverage weighing heavily on the score. Technical analysis and valuation also contribute to the low score, while recent corporate events provide some positive momentum.
To see Spark’s full report on BIAF stock, click here.
More about bioAffinity Technologies, Inc.
Average Trading Volume: 4,495,295
Technical Sentiment Signal: Sell
Current Market Cap: $6.89M
For an in-depth examination of BIAF stock, go to TipRanks’ Overview page.